A straightforward blood test capable of identifying the signature proteins associated with Alzheimer’s disease could offer a revolutionary way to detect the condition decades before any symptoms manifest, according to new research.
The findings suggest that the neurological disorder may already be present in midlife and linked to subtle cognitive differences.
